Insider filing · VKTX
J Matthew Singleton
Director
profile →
Viking Therapeutics, Inc.
VKTX · Healthcare · 22 filings in 24 months
ticker →
J Matthew Singleton sold $1.3M of Viking Therapeutics (VKTX)
Executed Oct 25 2024, disclosed Oct 25 2024, the same day.
Value, as filed
$1.3M
16,000 sh × $79.50
Executed
Oct 25 2024
the trade date, as filed
Disclosed
Oct 25 2024
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JSJ Matthew Singleton (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $1.3M of VKTX (16,000 sh × $79.50, as filed), executed Oct 25 2024.
The name
VKTXHealthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by J Matthew Singleton in VKTX
VKTXSALE
Viking Therapeutics, Inc.
$716K10,300 sh × $69.50
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET